Phenotypic characterization of Leishmania mexicana pentamidine-resistant promastigotes. Modulation of the resistance during in-vitro developmental life cycle

Comptes Rendus de l'Academie des Sciences - Serie III

Volumn 320, Issue 12, 1997, Pages 981-987

  Sereno, Denis ^a   Michon, Pascal ^a   Brajon, Nathalie ^a   Lemesre, Jean Loup ^a  

^a Laboratoire de Biologie Parasitaire   (France)

Author keywords

Amastigote; Drug resistance; Leishmania mexicana; Pentamidine; Promastigote

Indexed keywords

AMPHOTERICIN B; ANTIMONY TARTRATE; ARSENITE SODIUM; DIMINAZENE ACETURATE; MYCOPHENOLIC ACID; PENTAMIDINE; PRIMAQUINE; STIBOGLUCONATE SODIUM; VINBLASTINE;

AMASTIGOTE; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG RESISTANCE; LEISHMANIA MEXICANA; LIFE CYCLE; NONHUMAN; PERITONEUM MACROPHAGE; PHENOTYPE; PROMASTIGOTE;

EID: 0031437061     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0764-4469(97)82471-7     Document Type: Article

References (25)

1. Chulay J.D., Bhatt S.M., Muigai R., Ho M., Gachihi G., Were JB., Chunge C., Bryceson A.D.M. 1983. A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. J. Inf. Dis 148, 148-155
2. Bryceson A.D., Chulay J.D., Mugambi M., Were J.B., Gachichi G., Chunge C.N., Muigai J.B., Bhatt S.M., Ho M., Spencer H.C., Meme J., Anabwani G. 1985. Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with Pentamidine. Trans. Roy. Soc. Trop. Med. Hyg. 79, 705-714
3. Grögl M.,Thomason T.N., Franke E. 1992. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am. J. Trop. Med. Hyg. 47, 117-126
4. Ouellette M., Papadopoulou B. 1993. Mechanisms of drug resistance in Leishmania. Parasitol. Today 9, 150-153
5. Kink J.A., Chang K.P. 1987. Tunicamycin-resistant Leishmania mexicana amazonensis: Expression of virulence associated with an increased activity of N-acetylglucosaminyltransferase and amplification of its presumptive gene. Proc. Natl. Acad. Sci. USA. 84, 1253-1257
6. Detke S., Katakura K., Chang K.P. 1989. DNA amplification in arsenite-resistant Leishmania. Exp. Cell. Res 180, 161-170
7. Phélouzat M.A., Lawrence F., Robert-Gero M. 1993. Characterization of sinefungin-resistant Leishmania donovani promastigotes. Parasitol. Res. 79, 683-689
8. Bates P.A., Robertson C.D., Tetley L., Coombs G.H. 1992. Axenic cultivation and characterization of Leishmania mexicana amastigote-like forms. Parasitology 105, 193-202
9. Bates P.A. 1993. Axenic culture of Leishmania amastigotes. Parasitol. Today 9, 143-146
10. Lemesre J.L., Blanc M.P., Grébaut P., Zilberfab V., Carrière V. 1994. Culture continue des formes amastigotes de leishmanies en condition axénique. Réalisation du cycle évolutif in vitro. Méd. Armées 22, 99
11. Lemesre J.L. 1994. Brevet d'invention N° pCT/FR 94/00577
12. Lemesre J.L., Sereno D., Daulouède S., Veyret B., Brajon N., Vincendeau P. 1997. Leishmania spp.: Nitric Oxide-mediated metabolic inhibition of promastigote and axenically-grown amastigote forms. Exp. Parasital. 86, 58-68
13. Sereno D., Lemesre J.L, 1997. Use of an enzymatic micromethod to quantify amastigote stage of Leishmania amazonensis in vitro. Parasital. Res. 83, 401-403
14. Sereno D., Lemesre J.L. 1997. Axenically-cultured amastigote forms as an in vitro model for investigation of antileishmanial agents, Antimicrob. Agents Chemother. 262, 972-976
15. Hills M., Hudson C., Smith P.G. 1986. Global monitoring of the resistance of malarial parasites to drugs: statistical treatment of micro-test data. Working paper No. 2.8.5. Informal consultation on the epidemiology of drug resistance of malaria parasites, Geneva, Switzerland
16. Kweider M.K., Lemesre J.L., Santoro F., Kusnierz J.P., Sadigursky M., Capron A. 1989. Development of metacyclic Leishmania promastigotes is associated with the increasing expression of GP65, the major surface antigen. Parasite Immunol. 11, 197-209
17. Safa A.R.C., Glover J.L.,Sewell M.B., Meyers M.B., Biedler J.L., Felsted R.L. 1987. Identification of the multidrug resistance related membrane glycoprotein as an acceptor for calcium channel blockers. J. Biol. Chem. 262, 7884-7888
18. Bitonti A.J., Sjoerdsma A., McCann P.P., Kyle D.E., Oduola A.M.J., Rossan R.N., Milhous W.K., Davidson D.E. 1988. Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine. Science 242, 1301-1303
19. Flintoff W.F., Essani K. 1980. Methotrexate-resistant Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexate. Biochemistry 19,4321-4327
20. Endicott J.A., Ling V. 1989. The biochemistry of P-glycoprotein mediated multidrug resistance. Annu. Rev. Microbiol. 58, 137-171
21. Coons T., Hanson S., Bitonti A.J., Mc Cann P.P., Ullman B. 1990. Difluoromethyl ornithine resistance in Leishmania donovani is associated with increased ornithine decarboxylase activity. Mol. Biochem. Parasital. 39, 77-90
22. Katakura K., Peng Y., Pithawalla R., Detke S., Chang K.P. 1991. Tunicamycin-resistant variants from five species of Leishmania contain amplified DNA in extrachromosomal circles of different sizes with a transcriptionally active homologous region. Mol. Bio chem. Parasitol. 44, 233-244
23. Kartner N., Evernden-Porelle D., Bradley G., Ling V. 1985. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 316, 820-823
24. Hijazi Y.M., Anxiotis C.A., Navarro S., Steinberg S.M., Horowitz M.E.,Tsokos M. 1993. Immunohistochemical detection of P-glycoprotein in Ewing's Sarcoma and peripheral primitive neuroectodermal tumors before and after chemotherapy. Anat. Pathol. 102, 61-67
25. Basselin M., Lawrence F., Robert-Gero M. 1996. Pentamidine uptake in Lelshmania donovani and Leishmania amazonensis promastigotes and axenic amastigotes. Biochem. J. 315, 631-634